Back to Search Start Over

P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial.

Authors :
Perol, M.
Ahn, M.-J.
Cheng, Y.
Clarke, J.
Dingemans, A.-M.
Gay, C.
Navarro, A.
Schuler, M.
Yoshida, T.
Martinez, P.
Anderson, E.S.
Sands, J.
Source :
Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS206-S207, 2p
Publication Year :
2024

Details

Language :
English
ISSN :
15560864
Volume :
19
Issue :
10
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
180335159
Full Text :
https://doi.org/10.1016/j.jtho.2024.09.372